Home > Balance Sheet > SUN PHARMA ADVANCED RESEARCH COMPANY

SUN PHARMA ADVANCED RESEARCH COMPANY
Total Liabilities

    Back to Balance Sheet
SUN PHARMA ADVANCED RESEARCH COMPANY is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for SUN PHARMA ADVANCED RESEARCH COMPANY
Please provide your vote to see the results

SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Total Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023
Total Liabilities ₹2,169 Cr₹333 Cr₹514 Cr₹830 Cr

What is the latest Total Liabilities ratio of SUN PHARMA ADVANCED RESEARCH COMPANY ?

The latest Total Liabilities ratio of SUN PHARMA ADVANCED RESEARCH COMPANY is ₹2,169 Cr based on Mar2026 Consolidated results.
Year Total Liabilities
Mar2026₹2,169 Cr
Mar2025₹333 Cr
Mar2024₹514 Cr
Mar2023₹830 Cr

How is Total Liabilities of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?

Years Total Liabilities % Change
Mar2026 ₹2,169 Cr
550.79
Mar2025 ₹333 Cr
-35.14
Mar2024 ₹514 Cr
-38.11
Mar2023 ₹830 Cr -

Compare Total Liabilities of peers of SUN PHARMA ADVANCED RESEARCH COMPANY

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SUN PHARMA ADVANCED RESEARCH COMPANY ₹6,756.1 Cr 0.4% -21.3% 42.4% Stock Analytics
PRIME FOCUS ₹22,101.6 Cr -6.3% 11% 96.2% Stock Analytics
SAGILITY ₹20,410.6 Cr -1.1% 2.6% -2.9% Stock Analytics
SYNGENE INTERNATIONAL ₹16,253.7 Cr -1.1% -4.2% -42.6% Stock Analytics
INTERNATIONAL GEMOLOGICAL INSTITUTE ₹15,307.1 Cr -1.3% 2.1% -4.5% Stock Analytics
INDEGENE ₹13,695.2 Cr 2.6% 11.6% -3.9% Stock Analytics


SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SUN PHARMA ADVANCED RESEARCH COMPANY

0.4%

-21.3%

42.4%

SENSEX

-0.1%

2.4%

-3.3%


You may also like the below Video Courses